Expert Interview
Discussing the potential of Cidara's once-weekly echinocandin, rezafungin for the treatment and prevention of serious fungal infections
Ticker(s): CDTXInstitution: Emory University
- Assistant Professor of Medicine at Emory University specializing in infectious disease and critical care medicine
- Manages 5-10 patients a week with invasive fungal infections.
- Research focus in nosocomial infections, antibiotic stewardship, infection control, and pulmonary disorders
Please describe your background and practice setting.
Added By: ben_adminHow many patients with invasive fungal infections do you manage?
Added By: ben_adminWhat is the current standard of care for candidemia?
Added By: ben_adminWhat are your thoughts on the potential of Cidara therapeutics antifungal rezafungin?
Added By: ben_adminWhere would rezafungin fit into your current treatment algorithm?
Added By: ben_adminRank your excitement for Rezafungin on a scale of 1-10?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
